On July 1, Blue Cross Blue Shield of North Carolina introduced a machine-learning technology platform to make decisions about patients’ care and treatment. The ACR opposes its use on grounds that it may harm patients’ access to treatment and undermine the doctor-patient relationship.
Articles by From the College
CMS Releases CY24 Medicare Physician Fee Schedule & Quality Payment Program Updates
On July 13, the Centers for Medicare & Medicaid Services (CMS) released the Calendar Year 2024 Medicare Physician Fee Schedule and Quality Payment Program (QPP) updates. Notably, the Fee Schedule decreases the conversion factor, which coupled with reimbursement stagnation for payment updates and congressionally mandated cuts, has created financial instability for physicians across all specialties. …
Copay Accumulator & Maximizer Programs Threaten Access to Treatment
As health insurance companies and third-party benefit managers continue to use copay accumulators and maximizers to shift the cost of specialty drugs to patients, the ACR continues to advocate against programs that limit copay assistance.
Connect with Your Members of Congress in August
Legislators head home to their districts in August, providing a chance for you to engage them in personal conversations about healthcare policies and how their work affects rheumatology practices and patients.
Calling All Advocates: Advocates for Arthritis Applications Now Open
Applications are open for this year’s Advocates for Arthritis, which brings together patients and rheumatology professionals to advocate on Capitol Hill. It will be held Sept. 26–27 in Washington, D.C.
Rheumatology Priorities Advanced at Busy AMA House of Delegates Meeting
Two ACR-led resolutions on in-office specialty drug dispensing and the proposed NIH Public Access Plan passed the House of Delegates and will become AMA policy.
Open Now: New Federal Loan Repayment Program for Pediatric Rheumatologists
This program offers loan assistance of up to $100,000 to eligible pediatric medical subspecialists in exchange for a three-year, full-time service commitment at an approved facility in an underserved area. Pediatric rheumatologists are encouraged to apply.
After Pushback, Cigna Delays Modifier 25 Policy Changes
After significant pushback from the AMA, ACR and other medical societies, Cigna has delayed implementation of changes to its modifier 25 reimbursement policy, originally scheduled to take effect May 25.
ACR to Lead Resolutions at June AMA House of Delegates Meeting
The ACR will co-lead with the American Society of Clinical Oncology a resolution on in-office dispensing of specialty drugs and will lead 10 other specialty societies to advance a resolution on the proposed NIH Public Access Plan and equitable access to quality clinical research.
Charting a New Course Post-PHE
The public health emergency (PHE), in place since 2020, officially expired at midnight on May 11. The PHE declaration allowed significant flexibility in the healthcare system. The end of the PHE impacts several policies, including changes in Medicare and Medicaid policies. What do these changes mean for providers?
- « Previous Page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- …
- 94
- Next Page »